Simultaneous left renal pelvic and bilateral ureteral tumors producing carbohydrate antigen 19-9

International Journal of Urology

Volumn 3, Issue 3, 1996, Pages 231-233

  Mizutani, Youichi ^a   Terachi, Toshiro ^a   Yoshida, Toru ^a   Kakehi, Yoshiyuki ^a   Yoshida, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

CA19 9; Ileal graft; Renal pelvic tumor; Ureteral tumor

Indexed keywords

CA 19-9 ANTIGEN;

AGED; ARTICLE; CANCER SURGERY; CASE REPORT; CUFF; HUMAN; KIDNEY FUNCTION; KIDNEY PELVIS TUMOR; MALE; NEPHROURETERECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URETER TUMOR;

EID: 0029895832     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1996.tb00522.x     Document Type: Article

References (10)

1. Maruf NJ, Gode C, Kahn A, Cass AS. Synchronous tumors in both ureters and left renal pelvis. Urology 1983;21:305-307.
2. Crassweller PO. Bilateral primary carcinoma of the ureter with use of ileal graft for ureteral replacement. Br J Urol 1958;30:152-159.
3. Sakai H, Toyofuku K, Yogi Y, Minami Y, Kanetake H, Saito Y. Carbohydrate antigen 19-9 and carcinoembryonic antigen-producing transitional cell carcinoma of the ureter and bladder: a case report. J Urol 1993;150:182-184.
4. Kanal S, Takagi Y, Tanaka J, Miyake K. Simultaneous bilateral renal pelvic tumors: a case report. Acta Urol Jpn 1991;37:1703-1705.
5. Sidransky D, Frost P, Eschenbach AV, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin of bladder cancer. N Engl J Med 1992;326:737-740.
6. Harris AL, Neal DE. Bladder cancer-field versus clonal origin. N Engl J Med 1992;326:759-761.
7. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 1993;342:1087-1088.
8. Magnani JL, Brockhaus M, Smith DF, Ginburg V, Blaszczyk M, Mitchell KF, Steplewski Z, Koprowski H. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 1981;212: 55-58.
9. Abel PD, Cornell C, Buamah PK, Williams G. Assessment of serum CA 19.9 as a tumor marker in patients with carcinoma of the bladder and prostate. Br J Urol 1987;59:427-429.
10. Tizzani A, Cassetta G, Cicigoi A, Piana P, Cerchier A, Pecchio F, Piantino P. Tumor markers (CEA, TPA and CA 19-9) in urine of bladder cancer patients. Int J Biol Markers 1987;2:121-124.